Literature DB >> 12775627

Relationships between the pharmaceutical industry and patients' organisations.

Andrew Herxheimer1.   

Abstract

Entities:  

Keywords:  Health Care and Public Health

Mesh：

Year:  2003        PMID： 12775627      PMCID： PMC1126060          DOI： 10.1136/bmj.326.7400.1208

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  22 in total

1.  No more free lunches.

Authors:  Kamran Abbasi; Richard Smith
Journal:  BMJ       Date:  2003-05-31

2.  Industry funding of patients' support groups: declaration of competing interests is rare in Italian breast cancer associations.

Authors:  Paola Mosconi
Journal:  BMJ       Date:  2003-08-09

3.  Industry funding of patients' support groups: objectives of patients, clinicians, and industry are similar.

Authors:  Peter M Lapsley
Journal:  BMJ       Date:  2003-08-09

Review 4.  Patient empowerment as a component of health system reforms: rights, benefits and vested interests.

Authors:  Cinzia Colombo; Lorenzo Moja; Marien Gonzalez-Lorenzo; Alessandro Liberati; Paola Mosconi
Journal:  Intern Emerg Med       Date:  2012-01-26       Impact factor: 3.397

Review 5.  How NICE may be outflanked.

Authors:  R E Ferner; Sarah E McDowell
Journal:  BMJ       Date:  2006-05-27

6.  On the Nature and Strategies of Organized Interests in Health Care Policy Making.

Authors:  Damien Contandriopoulos
Journal:  Adm Soc       Date:  2011-01-01

7.  Assessing stakeholder opinion on relations between cancer patient groups and pharmaceutical companies in Europe.

Authors:  Susanna Leto di Priolo; Andras Fehervary; Phil Riggins; Kathy Redmond
Journal:  Patient       Date:  2012       Impact factor: 3.883

8.  Patient organisations and the reimbursement process for medicines: an exploratory study in eight European countries.

Authors:  Janneke Noordman; Liset van Dijk; Roland Friele
Journal:  BMC Health Serv Res       Date:  2010-02-22       Impact factor: 2.655

9.  Coalition Priorité Cancer and the pharmaceutical industry in Quebec: conflicts of interest in the reimbursement of expensive cancer drugs?

Authors:  David Hughes; Bryn Williams-Jones
Journal:  Healthc Policy       Date:  2013-08

10.  Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness.

Authors:  Susannah L Rose
Journal:  J Law Med Ethics       Date:  2013       Impact factor: 1.718
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.